cysteine has been researched along with laromustine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, J; King, I; Nassar, AE | 1 |
Buros, CM; Gerber, SA; Klinkerch, EJ; Kraus, TJ; Rice, KP; Schleicher, TR | 1 |
2 other study(ies) available for cysteine and laromustine
Article | Year |
---|---|
Characterization of short-lived electrophilic metabolites of the anticancer agent laromustine (VNP40101M).
Topics: Acetylcysteine; Antineoplastic Agents; Carbon Isotopes; Chromatography, High Pressure Liquid; Cysteine; Glutathione; Humans; Hydrazines; Magnetic Resonance Spectroscopy; Microsomes, Liver; NADP; Neoplasms; Spectrometry, Mass, Electrospray Ionization; Sulfonamides | 2011 |
Thioredoxin reductase is inhibited by the carbamoylating activity of the anticancer sulfonylhydrazine drug laromustine.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Carbamates; Carmustine; Cell Line, Tumor; Cysteine; Drug Screening Assays, Antitumor; Hydrazines; Hydrogen-Ion Concentration; Isocyanates; Mice; Molecular Sequence Data; Peptides; Rats; Sulfonamides; Tandem Mass Spectrometry; Thioredoxin-Disulfide Reductase; Time Factors | 2012 |